selegiline And NotRobert A. Hauser
List of bibliographic references
Number of relevant bibliographic references: 10.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000F56 | V. Pursiainen [Finlande] ; T. J. Korpelainen [Finlande] ; H. T. Haapaniemi [Finlande] ; A. K. Sotaniemi [Finlande] ; V. V. Myllyl [Finlande] | Selegiline and blood pressure in patients with Parkinson's disease |
| 001008 | Fernandez [États-Unis] ; Chen [États-Unis] | Monoamine Oxidase‐B Inhibition in the Treatment of Parkinson's Disease |
| 001A73 | D. A. M. C. Van De Vijver [Pays-Bas] ; R. A. C. Roos [Pays-Bas] ; P. A. F. Jansen [Pays-Bas] ; A. J. Porsius [Pays-Bas] ; A. De Boer [Pays-Bas] | Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records |
| 001D39 | H. Przuntek ; B. Conrad [Allemagne] ; J. Dichgans ; P. H. Kraus ; P. Krauseneck ; G. Pergande ; U. Rinne [Finlande] ; K. Schimrigk ; J. Schnitker ; H. P. Vogel [Allemagne] | SELEDO: a 5‐y‐ear long‐term trial on the effect of selegiline in early parkinsonian patients treated with levodopa |
| 001F92 | V. V. Myllyl [Finlande] ; K. A. Sotaniemi [Finlande] ; P. Hakulinen [Finlande] ; O. M Ki-Lkola [Finlande] ; E. H. Heinonen [Finlande] | Selegiline as the primary treatment of Parkinson's disease — a long‐term double‐blind study |
| 002682 | H. Allain [France] ; J. Cougnard [France] ; H-C. Neukirch [France] | Selegiline in de novo parkinsonian patients: The French selegiline multicenter trial (FSMT) |
| 002692 | J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease in relation to clinical features |
| 002693 | U. K. Rinne [Finlande] | New strategies in the treatment of early Parkinson's disease |
| 002703 | A. Lieberman [États-Unis] ; E. Fazzini [États-Unis] | Experience with selegiline and levodopa in advanced Parkinson's disease |
| 002725 | E. H. Heinonen [Finlande] ; R. Lammintausta [Finlande] | A review of the pharmacology of selegiline |
| This area was generated with Dilib version V0.6.23. |  |